Free Trial
→ The Trump Dump is starting; Get out of stocks now? (From Paradigm Press) (Ad) Buy ACCD Stock  Free ACCD Stock Alerts

Accolade (ACCD) Financials

Accolade logo
$7.02 0.00 (0.00%)
As of 04/8/2025
Compare
Annual Income Statements for Accolade

Annual Income Statements for Accolade

This table shows Accolade's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 2/29/2024 2/28/2023 2/28/2022
Net Income / (Loss) Attributable to Common Shareholders		 -100 -460 -123
Consolidated Net Income / (Loss)		 -100 -460 -123
Net Income / (Loss) Continuing Operations		 -100 -460 -123
Total Pre-Tax Income 		-99 -463 -129
Total Operating Income		 -114 -464 -126
Total Gross Profit		 192 164 141
Total Revenue		 414 363 310
Operating Revenue		 414 363 310
Total Cost of Revenue		 222 199 169
Operating Cost of Revenue		 222 199 169
Total Operating Expenses		 307 628 267
Selling, General & Admin Expense		 62 81 99
Marketing Expense		 100 99 87
Depreciation Expense		 45 46 43
Other Operating Expenses / (Income)		 99 101 84
Impairment Charge		 0.00 300 0.00
Other Special Charges / (Income)		 0.00 0.00 -45
Total Other Income / (Expense), net		 16 0.24 -3.04
Interest & Investment Income		 5.95 0.26 -2.91
Other Income / (Expense), net		 9.93 -0.02 -0.13
Income Tax Expense		 1.24 -3.62 -5.64
Basic Earnings per Share		 ($1.33) ($6.45) ($1.93)
Weighted Average Basic Shares Outstanding		 74.91M 71.28M 63.82M
Diluted Earnings per Share		 ($1.33) ($6.45) ($1.93)
Weighted Average Diluted Shares Outstanding		 74.91M 71.28M 63.82M
Weighted Average Basic & Diluted Shares Outstanding		 78.36M 73.63M 67.29M

Quarterly Income Statements for Accolade

This table shows Accolade's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022 5/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 -121 -24 -28 -7.51 -21 -33 -38 -30 -40 -47 -343
Consolidated Net Income / (Loss)		 -121 -24 -28 -7.51 -21 -33 -38 -30 -40 -47 -343
Net Income / (Loss) Continuing Operations		 -121 -24 -28 -7.51 -21 -33 -38 -30 -40 -47 -343
Total Pre-Tax Income 		-121 -24 -27 -6.78 -21 -33 -38 -30 -40 -46 -347
Total Operating Income		 -122 -25 -29 -7.90 -32 -35 -40 -31 -40 -46 -346
Total Gross Profit		 46 49 52 67 45 42 39 48 41 38 38
Total Revenue		 105 106 110 125 99 97 93 99 91 88 86
Operating Revenue		 105 106 110 125 99 97 93 99 91 88 86
Total Cost of Revenue		 59 57 59 58 55 55 54 51 50 50 48
Operating Cost of Revenue		 59 57 59 58 55 55 54 51 50 50 48
Total Operating Expenses		 169 75 81 75 77 77 79 79 81 84 384
Selling, General & Admin Expense		 16 17 16 14 15 16 16 20 20 21 20
Marketing Expense		 26 25 28 25 26 24 25 24 25 25 26
Depreciation Expense		 10 11 10 11 11 11 12 12 12 12 12
Other Operating Expenses / (Income)		 21 22 26 24 23 26 26 24 24 26 27
Impairment Charge		 96 - - - 0.00 - - - 0.00 0.00 300
Total Other Income / (Expense), net		 1.38 1.58 1.79 1.12 11 2.47 1.31 0.70 0.59 -0.37 -0.68
Interest & Investment Income		 1.45 1.69 1.70 1.61 1.71 1.71 0.92 0.74 0.39 -0.24 -0.63
Other Income / (Expense), net		 -0.07 -0.10 0.09 -0.49 9.28 0.75 0.39 -0.04 0.20 -0.13 -0.05
Income Tax Expense		 0.33 0.37 0.34 0.73 0.33 0.08 0.09 -0.05 0.08 0.25 -3.90
Basic Earnings per Share		 ($1.50) ($0.30) ($0.35) ($0.10) ($0.28) ($0.43) ($0.52) ($0.31) ($0.56) ($0.66) ($4.92)
Weighted Average Basic Shares Outstanding		 80.65M 80.07M 78.12M 74.91M 76.14M 75.49M 73.18M 71.28M 71.23M 70.48M 69.74M
Diluted Earnings per Share		 ($1.50) ($0.30) ($0.35) ($0.53) ($0.28) ($0.43) ($0.52) ($0.31) ($0.56) ($0.66) ($4.92)
Weighted Average Diluted Shares Outstanding		 80.65M 80.07M 78.12M 74.91M 76.14M 75.49M 73.18M 71.28M 71.23M 70.48M 69.74M
Weighted Average Basic & Diluted Shares Outstanding		 81.59M 80.54M 80.01M 78.36M 77.41M 76.23M 75.63M 73.63M 72.79M 71.94M 71.21M

Annual Cash Flow Statements for Accolade

This table details how cash moves in and out of Accolade's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 2/29/2024 2/28/2023 2/28/2022
Net Change in Cash & Equivalents		 -135 -45 -68
Net Cash From Operating Activities		 -16 -41 -62
Net Cash From Continuing Operating Activities		 -16 -41 -62
Net Income / (Loss) Continuing Operations		 -100 -460 -123
Consolidated Net Income / (Loss)		 -100 -460 -123
Depreciation Expense		 45 46 43
Amortization Expense		 5.22 3.70 2.95
Non-Cash Adjustments To Reconcile Net Income		 52 378 63
Changes in Operating Assets and Liabilities, net		 -19 -9.25 -48
Net Cash From Investing Activities		 -64 -7.23 -264
Net Cash From Continuing Investing Activities		 -64 -7.23 -264
Purchase of Property, Plant & Equipment		 -12 -7.23 -3.62
Acquisitions		 0.00 0.00 -260
Purchase of Investments		 -51 0.00 -100
Sale and/or Maturity of Investments		 0.00 0.00 100
Net Cash From Financing Activities		 -56 3.16 258
Net Cash From Continuing Financing Activities		 -56 3.16 258
Repayment of Debt		 -66 0.00 -8.37
Repurchase of Common Equity		 0.00 0.00 -0.06
Issuance of Debt		 0.00 0.00 288
Issuance of Common Equity		 3.58 2.93 4.70
Other Financing Activities, net		 7.02 0.24 -26
Cash Interest Paid		 1.64 1.64 0.93
Cash Income Taxes Paid		 0.40 0.16 0.12

Quarterly Cash Flow Statements for Accolade

This table details how cash moves in and out of Accolade's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022 5/31/2022
Net Change in Cash & Equivalents		 13 -15 2.99 -44 -62 -11 -18 -4.55 -5.00 -5.00 -30
Net Cash From Operating Activities		 -9.73 4.14 -7.12 5.95 5.21 -8.04 -19 -2.56 -4.69 -2.99 -30
Net Cash From Continuing Operating Activities		 -9.73 4.14 -7.12 5.95 5.21 -8.04 -19 -2.56 -4.69 -2.99 -30
Net Income / (Loss) Continuing Operations		 -121 -24 -28 -7.51 -21 -33 -38 -30 -40 -47 -343
Consolidated Net Income / (Loss)		 -121 -24 -28 -7.51 -21 -33 -38 -30 -40 -47 -343
Depreciation Expense		 10 11 10 11 11 11 12 12 12 12 12
Amortization Expense		 0.95 0.72 0.81 1.21 1.64 1.25 1.12 1.11 0.88 0.90 0.82
Non-Cash Adjustments To Reconcile Net Income		 101 14 16 13 6.53 17 15 16 25 16 322
Changes in Operating Assets and Liabilities, net		 -0.81 2.25 -6.34 -13 6.70 -4.39 -8.75 -0.59 -2.04 15 -22
Net Cash From Investing Activities		 21 -20 8.05 -53 -3.71 -3.29 -3.38 -2.41 -1.91 -1.63 -1.27
Net Cash From Continuing Investing Activities		 21 -20 8.05 -53 -3.71 -3.29 -3.38 -2.41 -1.91 -1.63 -1.27
Purchase of Property, Plant & Equipment		 -0.87 -1.05 -1.96 -2.11 -3.71 -3.29 -3.38 -2.41 -1.91 -1.63 -1.27
Purchase of Investments		 -4.92 - - - - - - - - - -
Sale and/or Maturity of Investments		 27 18 10 - - - 0.00 - - - -
Net Cash From Financing Activities		 1.14 0.01 2.07 3.00 -64 0.64 4.45 0.42 1.61 -0.37 1.51
Net Cash From Continuing Financing Activities		 1.14 0.01 2.07 3.00 -64 0.64 4.45 0.42 1.61 -0.37 1.51
Issuance of Common Equity		 1.14 - 1.94 - 1.59 - 1.99 - 1.14 0.64 1.15
Other Financing Activities, net		 0.00 0.01 0.12 3.00 0.91 0.64 2.46 0.42 0.47 -1.01 0.36
Cash Interest Paid		 0.60 0.07 0.58 0.05 0.77 0.05 0.77 0.10 0.72 0.05 0.77
Cash Income Taxes Paid		 -1.04 0.62 0.83 0.08 0.02 0.25 0.05 0.05 0.08 - 0.02

Annual Balance Sheets for Accolade

This table presents Accolade's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 2/29/2024 2/28/2023 2/28/2022
Total Assets		 788 903 1,286
Total Current Assets		 285 366 409
Cash & Equivalents		 186 321 366
Short-Term Investments		 51 0.00 -
Accounts Receivable		 28 27 31
Prepaid Expenses		 16 14 9.47
Other Current Assets		 4.37 4.02 3.02
Plant, Property, & Equipment, net		 19 15 12
Total Noncurrent Assets		 484 522 865
Goodwill		 278 278 578
Intangible Assets		 165 203 245
Other Noncurrent Operating Assets		 41 41 42
Total Liabilities & Shareholders' Equity		 788 903 1,286
Total Liabilities		 343 429 430
Total Current Liabilities		 108 119 112
Accounts Payable		 24 22 19
Current Deferred Revenue		 35 35 31
Current Employee Benefit Liabilities		 23 39 39
Other Current Liabilities		 25 23 23
Total Noncurrent Liabilities		 235 310 318
Long-Term Debt		 208 282 281
Noncurrent Deferred Revenue		 0.12 0.15 0.27
Other Noncurrent Operating Liabilities		 26 27 37
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 445 474 856
Total Preferred & Common Equity		 445 474 856
Total Common Equity		 445 474 856
Common Stock		 1,500 1,428 1,350
Retained Earnings		 -1,054 -954 -495
Accumulated Other Comprehensive Income / (Loss)		 -0.05 0.00 -

Quarterly Balance Sheets for Accolade

This table presents Accolade's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023
Period end date 11/30/2024 8/31/2024 5/31/2024 11/30/2023 8/31/2023 5/31/2023 11/30/2022 8/31/2022 5/31/2022
Total Assets		 647 756 767 785 854 876 914 932 944
Total Current Assets		 272 275 275 272 336 348 366 375 378
Cash & Equivalents		 186 173 189 230 292 303 326 331 336
Short-Term Investments		 40 61 42 - - - - - -
Accounts Receivable		 31 25 28 26 25 26 24 31 28
Prepaid Expenses		 12 11 13 12 14 15 12 10 10
Other Current Assets		 4.21 4.30 4.25 4.46 4.47 3.93 4.08 3.45 3.18
Plant, Property, & Equipment, net		 19 19 20 19 18 17 14 12 12
Total Noncurrent Assets		 356 462 472 494 500 511 534 545 555
Goodwill		 182 278 278 278 278 278 278 278 278
Intangible Assets		 139 148 157 175 184 193 214 224 234
Other Noncurrent Operating Assets		 35 37 38 41 38 40 42 42 43
Total Liabilities & Shareholders' Equity		 647 756 767 785 854 876 914 932 944
Total Liabilities		 334 333 332 351 417 422 428 425 410
Total Current Liabilities		 104 101 98 116 109 113 117 113 95
Accounts Payable		 21 20 19 21 20 19 21 21 18
Current Deferred Revenue		 38 41 39 53 48 44 44 45 37
Current Employee Benefit Liabilities		 33 27 22 26 25 28 35 31 23
Other Current Liabilities		 11 13 18 16 16 22 17 16 18
Total Noncurrent Liabilities		 231 232 234 235 308 309 311 313 314
Long-Term Debt		 209 209 209 208 283 283 282 282 281
Noncurrent Deferred Revenue		 0.07 0.09 0.10 0.12 0.10 0.14 0.26 0.28 0.28
Other Noncurrent Operating Liabilities		 21 23 25 0.17 24 26 29 31 33
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 313 423 435 435 438 454 486 506 535
Total Preferred & Common Equity		 313 423 435 435 438 454 486 506 535
Total Common Equity		 313 423 435 435 438 454 486 506 535
Common Stock		 1,540 1,529 1,517 1,481 1,463 1,447 1,410 1,390 1,372
Retained Earnings		 -1,227 -1,106 -1,082 -1,047 -1,026 -993 -924 -884 -837
Accumulated Other Comprehensive Income / (Loss)		 0.02 0.03 -0.03 - - - - - -

Annual Metrics And Ratios for Accolade

This table displays calculated financial ratios and metrics derived from Accolade's official financial filings.

Metric 2024 2023 2022
Period end date 2/29/2024 2/28/2023 2/28/2022
Growth Metrics		 - - -
Revenue Growth		 14.09% 17.13% 81.98%
EBITDA Growth		 86.91% -414.85% -116.72%
EBIT Growth		 77.45% -268.30% -168.22%
NOPAT Growth		 75.31% -268.67% -168.78%
Net Income Growth		 78.29% -273.32% -143.08%
EPS Growth		 79.38% -234.20% -12.21%
Operating Cash Flow Growth		 60.28% 34.72% -147.11%
Free Cash Flow Firm Growth		 -657.54% 101.23% -3,437.01%
Invested Capital Growth		 -4.16% -43.55% 1,890.61%
Revenue Q/Q Growth		 6.64% 1.47% 12.53%
EBITDA Q/Q Growth		 29.47% -0.29% -23.20%
EBIT Q/Q Growth		 17.93% -0.28% -25.01%
NOPAT Q/Q Growth		 16.91% -0.30% -24.88%
Net Income Q/Q Growth		 18.68% 0.89% -31.97%
EPS Q/Q Growth		 -19.82% 1.83% 0.00%
Operating Cash Flow Q/Q Growth		 34.48% -0.68% -25.53%
Free Cash Flow Firm Q/Q Growth		 33.82% -43.93% -1.69%
Invested Capital Q/Q Growth		 -5.14% -1.63% -1.90%
Profitability Metrics		 - - -
Gross Margin		 46.36% 45.23% 45.48%
EBITDA Margin		 -13.07% -113.85% -25.90%
Operating Margin		 -27.63% -127.64% -40.55%
EBIT Margin		 -25.23% -127.64% -40.60%
Profit (Net Income) Margin		 -24.09% -126.58% -39.71%
Tax Burden Percent		 101.25% 99.22% 95.62%
Interest Burden Percent		 94.31% 99.95% 102.31%
Effective Tax Rate		 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -18.81% -53.82% -24.19%
ROIC Less NNEP Spread (ROIC-NNEP)		 39.69% 164.32% -10.66%
Return on Net Nonoperating Assets (RNNOA)		 -2.91% -15.32% 4.44%
Return on Equity (ROE)		 -21.71% -69.14% -19.75%
Cash Return on Invested Capital (CROIC)		 -14.56% 1.84% -117.01%
Operating Return on Assets (OROA)		 -12.36% -42.36% -14.29%
Return on Assets (ROA)		 -11.80% -42.00% -13.98%
Return on Common Equity (ROCE)		 -21.71% -69.14% -19.75%
Return on Equity Simple (ROE_SIMPLE)		 -22.40% -97.02% -14.39%
Net Operating Profit after Tax (NOPAT)		 -80 -324 -88
NOPAT Margin		 -19.34% -89.35% -28.39%
Net Nonoperating Expense Percent (NNEP)		 -58.50% -218.14% -13.53%
Cost of Revenue to Revenue		 53.64% 54.77% 54.52%
SG&A Expenses to Revenue		 15.00% 22.36% 31.97%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 73.98% 172.87% 86.04%
Earnings before Interest and Taxes (EBIT)		 -105 -464 -126
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -54 -413 -80
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 1.78 1.71 1.41
Price to Tangible Book Value (P/TBV)		 424.97 0.00 36.25
Price to Revenue (P/Rev)		 1.92 2.23 3.88
Price to Earnings (P/E)		 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.83 1.77 1.45
Enterprise Value to Revenue (EV/Rev)		 1.85 2.12 3.61
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 69.23 0.00
Leverage & Solvency		 - - -
Debt to Equity		 0.47 0.60 0.33
Long-Term Debt to Equity		 0.47 0.60 0.33
Financial Leverage		 -0.07 -0.09 -0.42
Leverage Ratio		 1.84 1.65 1.41
Compound Leverage Factor		 1.74 1.65 1.45
Debt to Total Capital		 31.88% 37.34% 24.70%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 31.88% 37.34% 24.70%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 68.12% 62.66% 75.30%
Debt to EBITDA		 -3.85 -0.68 -3.50
Net Debt to EBITDA		 0.53 0.09 1.06
Long-Term Debt to EBITDA		 -3.85 -0.68 -3.50
Debt to NOPAT		 -2.60 -0.87 -3.19
Net Debt to NOPAT		 0.36 0.12 0.97
Long-Term Debt to NOPAT		 -2.60 -0.87 -3.19
Altman Z-Score		 -0.13 -1.31 1.34
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 2.64 3.06 3.66
Quick Ratio		 2.45 2.91 3.55
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 -62 11 -902
Operating Cash Flow to CapEx		 -129.54% -563.16% -1,723.80%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.49 0.33 0.35
Accounts Receivable Turnover		 15.23 12.63 14.54
Inventory Turnover		 0.00 0.00 0.00
Fixed Asset Turnover		 24.44 27.35 29.49
Accounts Payable Turnover		 9.58 9.77 10.68
Days Sales Outstanding (DSO)		 23.96 28.90 25.10
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 38.09 37.38 34.16
Cash Conversion Cycle (CCC)		 -14.13 -8.48 -9.06
Capital & Investment Metrics		 - - -
Invested Capital		 417 435 771
Invested Capital Turnover		 0.97 0.60 0.85
Increase / (Decrease) in Invested Capital		 -18 -336 814
Enterprise Value (EV)		 765 770 1,119
Market Capitalization		 793 809 1,204
Book Value per Share		 $5.75 $6.51 $12.78
Tangible Book Value per Share		 $0.02 ($0.10) $0.50
Total Capital		 654 756 1,136
Total Debt		 208 282 281
Total Long-Term Debt		 208 282 281
Net Debt		 -29 -39 -85
Capital Expenditures (CapEx)		 12 7.23 3.62
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -60 -75 -68
Debt-free Net Working Capital (DFNWC)		 177 247 297
Net Working Capital (NWC)		 177 247 297
Net Nonoperating Expense (NNE)		 20 135 35
Net Nonoperating Obligations (NNO)		 -29 -39 -85
Total Depreciation and Amortization (D&A)		 50 50 46
Debt-free, Cash-free Net Working Capital to Revenue		 -14.48% -20.53% -22.09%
Debt-free Net Working Capital to Revenue		 42.74% 67.89% 95.92%
Net Working Capital to Revenue		 42.74% 67.89% 95.92%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 ($1.33) ($6.45) ($1.93)
Adjusted Weighted Average Basic Shares Outstanding		 74.91M 71.28M 63.82M
Adjusted Diluted Earnings per Share		 ($1.33) ($6.45) ($1.93)
Adjusted Weighted Average Diluted Shares Outstanding		 74.91M 71.28M 63.82M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 78.36M 73.63M 67.29M
Normalized Net Operating Profit after Tax (NOPAT)		 -80 -115 -120
Normalized NOPAT Margin		 -19.34% -31.58% -38.64%
Pre Tax Income Margin		 -23.79% -127.57% -41.53%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% -0.05%

Quarterly Metrics And Ratios for Accolade

This table displays calculated financial ratios and metrics derived from Accolade's official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 11/30/2024 8/31/2024 5/31/2024 2/29/2024 11/30/2023 8/31/2023 5/31/2023 2/28/2023 11/30/2022 8/31/2022 5/31/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.73% 9.80% 18.49% 26.06% 9.26% 10.52% 9.00% 5.62% 8.98% 19.59% 43.68%
EBITDA Growth		 -1,085.68% 37.95% 32.98% 122.32% 66.09% 33.32% 92.06% -7.01% -171.92% 46.52% -760.66%
EBIT Growth		 -445.43% 26.72% 26.21% 73.13% 44.16% 25.16% 88.66% -4.33% -251.22% 38.15% -619.96%
NOPAT Growth		 -285.62% 28.58% 26.70% 74.68% 21.45% 23.31% 88.55% -4.61% -222.22% 38.33% -620.69%
Net Income Growth		 -475.69% 27.09% 28.16% 75.33% 47.17% 29.44% 88.80% 11.93% -277.19% 25.40% -603.85%
EPS Growth		 -435.71% 30.23% 32.69% -70.97% 50.00% 34.85% 89.43% 27.91% -280.65% 31.96% -485.71%
Operating Cash Flow Growth		 -287.01% 151.56% 63.08% 332.55% 210.93% -168.56% 36.68% -12.04% 78.10% 72.86% -10.31%
Free Cash Flow Firm Growth		 392.48% 220.34% -98.39% -95.99% -106.18% -98.56% 105.43% 137.60% 139.73% 133.28% 23.33%
Invested Capital Growth		 -32.44% -7.19% -4.75% -4.16% -0.62% -6.29% -9.67% -43.55% -43.71% -40.95% 27.21%
Revenue Q/Q Growth		 -1.22% -3.72% -11.51% 25.62% 2.59% 3.90% -5.86% 8.88% 3.77% 2.47% -8.78%
EBITDA Q/Q Growth		 -701.95% 21.75% -530.17% 143.92% 58.03% 15.47% -43.24% 33.25% 17.49% 89.94% -1,831.32%
EBIT Q/Q Growth		 -384.75% 12.80% -245.10% 62.61% 34.88% 12.19% -25.67% 22.29% 12.72% 86.70% -1,056.48%
NOPAT Q/Q Growth		 -386.46% 13.44% -267.84% 75.10% 9.91% 11.16% -27.07% 22.77% 12.04% 86.73% -1,060.73%
Net Income Q/Q Growth		 -406.66% 13.26% -267.55% 64.36% 35.83% 14.54% -26.21% 23.67% 14.30% 86.43% -892.08%
EPS Q/Q Growth		 -400.00% 14.29% 33.96% -89.29% 34.88% 17.31% -67.74% 44.64% 15.15% 86.59% -1,044.19%
Operating Cash Flow Q/Q Growth		 -334.89% 158.20% -219.64% 14.33% 164.75% 58.32% -653.69% 45.46% -56.77% 90.17% -1,233.67%
Free Cash Flow Firm Q/Q Growth		 331.61% 4,278.30% -97.60% 164.62% -572.72% -78.01% -94.03% -0.42% 10.51% 182.64% 58.66%
Invested Capital Q/Q Growth		 -25.36% -3.77% -0.84% -5.14% 2.54% -1.25% -0.22% -1.63% -3.31% -4.82% -37.64%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.25% 46.48% 46.94% 53.38% 45.14% 42.89% 41.86% 48.45% 44.57% 43.14% 44.33%
EBITDA Margin		 -106.02% -13.06% -16.07% 3.31% -9.45% -23.11% -28.41% -18.67% -30.46% -38.30% -390.16%
Operating Margin		 -116.42% -23.64% -26.30% -6.33% -31.92% -36.35% -42.51% -31.49% -44.40% -52.38% -404.59%
EBIT Margin		 -116.49% -23.74% -26.21% -6.72% -22.58% -35.57% -42.09% -31.53% -44.18% -52.53% -404.65%
Profit (Net Income) Margin		 -115.42% -22.50% -24.98% -6.01% -21.20% -33.89% -41.20% -30.73% -43.84% -53.08% -400.83%
Tax Burden Percent		 100.27% 101.59% 101.23% 110.76% 101.60% 100.26% 100.24% 99.83% 100.19% 100.54% 98.88%
Interest Burden Percent		 98.81% 93.32% 94.14% 80.79% 92.40% 95.03% 97.65% 97.63% 99.04% 100.51% 100.18%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -98.87% -17.66% -18.75% -4.31% -19.69% -21.83% -24.13% -13.28% -18.12% -20.86% -221.76%
ROIC Less NNEP Spread (ROIC-NNEP)		 532.27% 19.29% 15.84% 1.57% -25.54% 6.40% 4.66% 0.60% 31.41% 344.77% -44.26%
Return on Net Nonoperating Assets (RNNOA)		 -8.04% -0.77% -0.75% -0.12% 1.08% -0.39% -0.35% -0.06% -1.15% -2.19% 5.16%
Return on Equity (ROE)		 -106.91% -18.43% -19.49% -4.42% -18.61% -22.22% -24.48% -13.34% -19.27% -23.04% -216.60%
Cash Return on Invested Capital (CROIC)		 3.66% -8.44% -12.29% -14.56% -21.25% -16.64% -13.89% 1.84% 3.23% 6.59% -93.07%
Operating Return on Assets (OROA)		 -72.63% -13.00% -13.77% -3.29% -10.32% -15.14% -17.15% -10.46% -14.52% -16.72% -148.12%
Return on Assets (ROA)		 -71.97% -12.33% -13.12% -2.95% -9.69% -14.42% -16.79% -10.20% -14.41% -16.90% -146.72%
Return on Common Equity (ROCE)		 -106.91% -18.43% -19.49% -4.42% -18.61% -22.22% -24.48% -13.34% -19.27% -23.04% -216.60%
Return on Equity Simple (ROE_SIMPLE)		 -57.60% -18.93% -20.44% 0.00% -28.23% -32.34% -34.18% 0.00% -95.44% -79.28% -78.06%
Net Operating Profit after Tax (NOPAT)		 -86 -18 -20 -5.53 -22 -25 -28 -22 -28 -32 -242
NOPAT Margin		 -81.50% -16.55% -18.41% -4.43% -22.34% -25.44% -29.76% -22.05% -31.08% -36.67% -283.21%
Net Nonoperating Expense Percent (NNEP)		 -631.14% -36.95% -34.58% -5.88% 5.85% -28.23% -28.79% -13.88% -49.53% -365.63% -177.50%
Return On Investment Capital (ROIC_SIMPLE)		 -16.39% - - - -3.32% - - - - - -
Cost of Revenue to Revenue		 55.75% 53.52% 53.06% 46.62% 54.86% 57.11% 58.14% 51.55% 55.43% 56.86% 55.67%
SG&A Expenses to Revenue		 15.42% 15.55% 14.49% 11.46% 15.57% 16.79% 17.25% 20.11% 22.03% 23.98% 23.66%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 160.67% 70.12% 73.24% 59.71% 77.06% 79.24% 84.37% 79.94% 88.97% 95.53% 448.92%
Earnings before Interest and Taxes (EBIT)		 -122 -25 -29 -8.39 -22 -34 -39 -31 -40 -46 -346
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -111 -14 -18 4.13 -9.39 -22 -26 -18 -28 -34 -334
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.99 0.82 1.27 1.78 1.53 2.33 1.95 1.71 1.31 1.43 0.81
Price to Tangible Book Value (P/TBV)		 0.00 0.00 1,008.67 424.97 0.00 0.00 0.00 0.00 0.00 173.55 19.64
Price to Revenue (P/Rev)		 0.70 0.79 1.29 1.92 1.71 2.68 2.39 2.23 1.78 2.07 1.29
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.99 0.81 1.29 1.83 1.53 2.36 2.00 1.77 1.34 1.48 0.79
Enterprise Value to Revenue (EV/Rev)		 0.66 0.73 1.23 1.85 1.73 2.66 2.34 2.12 1.65 1.93 1.12
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 39.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 21.85 0.00 0.00 0.00 0.00 0.00 0.00 69.23 29.82 16.65 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.67 0.49 0.48 0.47 0.54 0.65 0.62 0.60 0.58 0.56 0.53
Long-Term Debt to Equity		 0.67 0.49 0.48 0.47 0.54 0.65 0.62 0.60 0.58 0.56 0.53
Financial Leverage		 -0.02 -0.04 -0.05 -0.07 -0.04 -0.06 -0.08 -0.09 -0.04 -0.01 -0.12
Leverage Ratio		 1.92 1.87 1.85 1.84 1.85 1.89 1.84 1.65 1.71 1.78 1.89
Compound Leverage Factor		 1.89 1.75 1.74 1.49 1.71 1.80 1.80 1.61 1.69 1.78 1.89
Debt to Total Capital		 40.08% 33.08% 32.42% 31.88% 35.07% 39.28% 38.37% 37.34% 36.71% 35.73% 34.46%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 40.08% 33.08% 32.42% 31.88% 35.07% 39.28% 38.37% 37.34% 36.71% 35.73% 34.46%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 59.92% 66.92% 67.58% 68.12% 64.93% 60.72% 61.63% 62.66% 63.29% 64.27% 65.54%
Debt to EBITDA		 -1.51 -5.67 -4.60 -3.85 -3.06 -2.98 -2.66 -0.68 -0.68 -0.81 -0.75
Net Debt to EBITDA		 0.12 0.68 0.48 0.53 -0.06 0.09 0.19 0.09 0.11 0.14 0.15
Long-Term Debt to EBITDA		 -1.51 -5.67 -4.60 -3.85 -3.06 -2.98 -2.66 -0.68 -0.68 -0.81 -0.75
Debt to NOPAT		 -1.62 -3.18 -2.87 -2.60 -2.44 -2.76 -2.57 -0.87 -0.87 -1.02 -0.95
Net Debt to NOPAT		 0.12 0.38 0.30 0.36 -0.05 0.09 0.18 0.12 0.14 0.18 0.18
Long-Term Debt to NOPAT		 -1.62 -3.18 -2.87 -2.60 -2.44 -2.76 -2.57 -0.87 -0.87 -1.02 -0.95
Altman Z-Score		 -1.72 -0.67 -0.26 0.28 -0.09 0.42 0.27 0.27 0.05 0.24 -1.10
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.63 2.72 2.80 2.64 2.35 3.08 3.09 3.06 3.14 3.33 3.95
Quick Ratio		 2.47 2.57 2.62 2.45 2.21 2.91 2.92 2.91 3.00 3.21 3.81
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 57 13 0.30 13 -19 4.12 19 314 315 285 -345
Operating Cash Flow to CapEx		 -1,115.01% 395.04% -364.19% 282.44% 140.22% -244.61% -571.13% -106.05% -245.53% -183.39% -2,394.73%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.62 0.55 0.53 0.49 0.46 0.43 0.41 0.33 0.33 0.32 0.37
Accounts Receivable Turnover		 15.88 17.46 15.98 15.23 15.62 13.59 13.54 12.63 14.29 14.21 14.45
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 23.64 24.00 23.80 24.44 23.70 25.23 26.05 27.35 28.04 28.62 27.98
Accounts Payable Turnover		 11.09 11.37 11.79 9.58 10.24 10.37 11.18 9.77 14.31 12.53 14.68
Days Sales Outstanding (DSO)		 22.98 20.91 22.84 23.96 23.37 26.85 26.96 28.90 25.54 25.69 25.26
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 32.90 32.09 30.96 38.09 35.65 35.20 32.65 37.38 25.51 29.13 24.86
Cash Conversion Cycle (CCC)		 -9.92 -11.18 -8.12 -14.13 -12.28 -8.35 -5.69 -8.48 0.04 -3.44 0.40
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 297 398 413 417 440 429 434 435 442 457 481
Invested Capital Turnover		 1.21 1.07 1.02 0.97 0.88 0.86 0.81 0.60 0.58 0.57 0.78
Increase / (Decrease) in Invested Capital		 -143 -31 -21 -18 -2.73 -29 -46 -336 -343 -317 103
Enterprise Value (EV)		 295 322 533 765 670 1,011 866 770 591 676 377
Market Capitalization		 311 347 555 793 666 1,020 887 809 635 725 432
Book Value per Share		 $3.89 $5.29 $5.55 $5.75 $5.70 $5.79 $6.17 $6.51 $6.76 $7.11 $7.94
Tangible Book Value per Share		 ($0.10) ($0.03) $0.01 $0.02 ($0.24) ($0.32) ($0.23) ($0.10) ($0.08) $0.06 $0.33
Total Capital		 522 632 644 654 670 721 737 756 768 788 816
Total Debt		 209 209 209 208 235 283 283 282 282 282 281
Total Long-Term Debt		 209 209 209 208 235 283 283 282 282 282 281
Net Debt		 -16 -25 -22 -29 4.78 -9.03 -20 -39 -44 -49 -55
Capital Expenditures (CapEx)		 0.87 1.05 1.96 2.11 3.71 3.29 3.38 2.41 1.91 1.63 1.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -57 -61 -54 -60 -74 -65 -67 -75 -76 -69 -54
Debt-free Net Working Capital (DFNWC)		 169 174 177 177 156 227 236 247 250 262 282
Net Working Capital (NWC)		 169 174 177 177 156 227 236 247 250 262 282
Net Nonoperating Expense (NNE)		 36 6.33 7.26 1.98 -1.14 8.18 11 8.60 12 14 101
Net Nonoperating Obligations (NNO)		 -16 -25 -22 -29 4.78 -9.03 -20 -39 -44 -49 -54
Total Depreciation and Amortization (D&A)		 11 11 11 13 13 12 13 13 12 12 12
Debt-free, Cash-free Net Working Capital to Revenue		 -12.67% -13.75% -12.47% -14.48% -18.94% -17.08% -18.10% -20.53% -21.24% -19.55% -15.93%
Debt-free Net Working Capital to Revenue		 37.80% 39.39% 40.97% 42.74% 40.26% 59.80% 63.57% 67.89% 69.75% 74.81% 83.95%
Net Working Capital to Revenue		 37.80% 39.39% 40.97% 42.74% 40.26% 59.80% 63.57% 67.89% 69.75% 74.81% 83.95%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($1.50) ($0.30) ($0.35) ($0.10) ($0.28) ($0.43) ($0.52) ($0.31) ($0.56) ($0.66) ($4.92)
Adjusted Weighted Average Basic Shares Outstanding		 80.65M 80.07M 78.12M 74.91M 76.14M 75.49M 73.18M 71.28M 71.23M 70.48M 69.74M
Adjusted Diluted Earnings per Share		 ($1.50) ($0.30) ($0.35) ($0.53) ($0.28) $0.00 ($0.52) ($0.31) ($0.56) ($0.66) ($4.92)
Adjusted Weighted Average Diluted Shares Outstanding		 80.65M 80.07M 78.12M 74.91M 76.14M 0.00 73.18M 71.28M 71.23M 70.48M 69.74M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 81.59M 80.54M 80.01M 78.36M 77.41M 76.23M 75.63M 73.63M 72.79M 71.94M 71.21M
Normalized Net Operating Profit after Tax (NOPAT)		 -18 -18 -20 -5.53 -22 -25 -28 -22 -28 -32 -32
Normalized NOPAT Margin		 -17.23% -16.55% -18.41% -4.43% -22.34% -25.44% -29.76% -22.05% -31.08% -36.67% -37.92%
Pre Tax Income Margin		 -115.11% -22.15% -24.67% -5.43% -20.86% -33.80% -41.10% -30.78% -43.76% -52.80% -405.39%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Accolade's Financials

When does Accolade's financial year end?

According to the most recent income statement we have on file, Accolade's fiscal year ends in February. Their fiscal year 2024 ended on February 29, 2024.

How has Accolade's net income changed over the last 2 years?

Accolade's net income appears to be on a downward trend, with a most recent value of -$99.81 million in 2024, falling from -$123.12 million in 2022. The previous period was -$459.65 million in 2023. Check out Accolade's forecast to explore projected trends and price targets.

What is Accolade's operating income?
Accolade's total operating income in 2024 was -$114.45 million, based on the following breakdown:
  • Total Gross Profit: $192.06 million
  • Total Operating Expenses: $306.51 million
How has Accolade revenue changed over the last 2 years?

Over the last 2 years, Accolade's total revenue changed from $310.02 million in 2022 to $414.29 million in 2024, a change of 33.6%.

How much debt does Accolade have?

Accolade's total liabilities were at $342.69 million at the end of 2024, a 20.2% decrease from 2023, and a 20.3% decrease since 2022.

How much cash does Accolade have?

In the past 2 years, Accolade's cash and equivalents has ranged from $185.72 million in 2024 to $365.85 million in 2022, and is currently $185.72 million as of their latest financial filing in 2024.

How has Accolade's book value per share changed over the last 2 years?

Over the last 2 years, Accolade's book value per share changed from 12.78 in 2022 to 5.75 in 2024, a change of -55.0%.


Related Companies

This page (NASDAQ:ACCD) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Elon Set to Shock the World on June 1st?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
Massive new energy source found in Utah
NEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...
Stansberry Research | Sponsored